Piramal Pharma (NSE:PPLPHARMA) Accounts Payable & Accrued Expense : ₹15,787 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Accounts Payable & Accrued Expense?

Piramal Pharma's quarterly accounts payable & accrued expense declined from Sep. 2023 (₹14,793 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹15,787 Mil).

Piramal Pharma's annual accounts payable & accrued expense increased from Mar. 2022 (₹12,086 Mil) to Mar. 2023 (₹12,135 Mil) and increased from Mar. 2023 (₹12,135 Mil) to Mar. 2024 (₹15,787 Mil).

Piramal Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Piramal Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Accounts Payable & Accrued Expense Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

11,858.10

12,086.40

12,135.20

15,786.70

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial							12,135.20	-	14,792.70	-	15,786.70

Piramal Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines